Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: Association with tumor progression in squamous carcinoma

Laboratory Investigation

Volumn 74, Issue 1, 1996, Pages 158-167

  Gazzeri, Sylvie ^a   Brambilla, Elisabeth ^a,b   Negoescu, Adrien ^a   Thoraval, Didier ^c   Veron, Michel ^d   Moro, Denis ^a   Brambilla, Christian ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b UNIV GRENOBLE ALPES   (France)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE;

ARTICLE; CANCER STAGING; CANCER SURGERY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NEUROENDOCRINE TUMORS; NUCLEOSIDE-DIPHOSPHATE KINASE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS;

EID: 0030034952     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aryee DNT, Ströbel T, Kos K, Salzer-Kuntschik M, Zoubek A, Veron M, Ambros IM, Traincart F, Gadner H, and Kovar H (1995). High nm 23-H1/NDPK-A expression in ewing tumors: Paradoxical immunohistochemical reactivity and lack of prognostic significance. Int J Cancer 64:104-111.
2. Banks L, Matlashewski G, and Crawford L (1986). Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159: 529-534.
3. Bertheau P, De La Rosa A, Steeg PS, and Merino MJ (1994). Nm23 protein in neoplastic and nonneoplastic thyroid tissues. Am J Pathol 145:26-32.
4. Bevilacqua G, Sobel ME, Liotta LA, and Steeg P (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185-5190.
5. Biggs J, Hersperger E, Steeg P, Liotta IA, and Shearn A (1990). A drosophilia gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63:933-940.
6. Brambilla E, Moro D, Veale D, Brichon PY, Stoebner P, Paramelle B, and Brambilla C (1993). Basal cell (basaloïd) carcinoma of the lung. Human Pathol 23:993-1003.
7. Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, and Hanash SM (1994). nm23-H1 mutation in neuroblastoma. Nature 370:335-336.
8. Engel M, Theisinger B, Seib T, Seitz G, Huwer H, Zang KD, Welter C, and Dooley S (1993). High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differenciation and advanced tumor stages. Int J Cancer 55:375-379.
9. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, and Fodstad O (1992). Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression. Cancer Res 52:6088-6091.
10. Gazzeri S, Brambilla E, Jacrot M, Chauvin C, Benabid AL, and Brambilla C (1991). Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res 51:2566-2571.
11. Gilles AM, Presecan E, Vonica A, and Lascu I (1991). Nucleoside diphosphate kinase from human erythrocytes. J Biol Chem 266:8784-8789.
12. Hahnel E, Dawkins H, Robbins P, and Hahnel R (1994). Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues. Int J Cancer 58:157-160.
13. Hailat N, Keim DR, Melhem RF, Zhu X, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, and Hanash S (1991). High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345.
14. Haut M, Steeg P, Willson JKV, and Markowitz SD (1991). Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83:712-716.
15. Hennessy C, Henry JA, May FEB, Westley BR, Angus B, and Lennard TWJ (1991). Expression of the antimetastatic gene nm23 in human breast cancer: An association with good prognosis. J Natl Cancer Inst 83:281-285.
16. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi R, and Kimura N (1992). Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 66:533-536.
17. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki Y, Kurashima C, Utsuyama M, and Hirokawa K (1991). Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83:1249-1250.
18. Igawa M, Rukstalis DB, Tanabe T, and Chodak GW (1994). High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res 54:1313-1318.
19. Kantor JD, McCormic B, Steeg P, and Zetter BR (1993). Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 53:1971-1973.
20. Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I, and Takagi H (1994). Expression of nm23-H1 RNA levels in human gastric cancer tissues. Cancer 73:259-265.
21. Leone A, Flatow U, Richter King C, Sandeen MA, Margulies IMK, Liotta LA, and Steeg P (1991). Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35.
22. Leone A, McBride OW, Weston A, Wang MG, Anglard P, Cropp CS, Goepel JR, Lidereau R, Callahan R, Linehan WM, Rees RC, Harris CC, Liotta LA, and Steeg P (1991). Somatic allelic deletion of nm23 in human cancer. Cancer Res 51: 2490-2493.
23. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, and Steeg PS (1993). Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865.
24. Liotta LA, Stetler-Stevenson W, and Steeg PS (1991). Metastasis suppressor genes. Important Adv Oncol 85-100.
25. MacDonald NJ, De la Rosa A, Benedict MA, Freije JMP, Krutsch H, and Steeg P (1993). A serine phosphorylation of nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268:25780-25789.
26. Mountain CF (1986). A new international staging system for lung cancer. Chest 89:225-233.
27. Myeroff LL and Markowitz D (1993). Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 85:147-152.
28. Ozeki Y, Takishima K, and Mamiya G (1994). Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: Association with tumor progression in clara cell type. Jpn J Cancer 85:840-846.
29. Postel EH and Ferrone CA (1994). Nucleoside diphosphate kinase enzyme activity of nm23-H2/puF is not required for its DNA binding and in vitro transcriptional functions. J Biol Chem 269:8627-8630.
30. Postel EH, Berberich SJ, Flint SJ, and Ferrone CA (1993). Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478-480.
31. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IMK, King CR, Liotta LA, and Steeg PS (1989). Reduced nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 342:177-180.
32. Sastre-Garau X, Lacombe ML, Jouve M, Veron M, and Magdelenat H (1992). Nucleoside diphosphate kinase/nm23 expression in breast cancer: Lack of correlation with lymphnode metastasis. Int J Cancer 50:533-538.
33. Sawan A, Lascu I, Veron M, Anderson JJ, Wright C, Horne CHW, and Angus B (1994). NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: An immunohistochemical study. J Pathol 172:27-34.
34. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, and Steeg P (1991). Identification of a second human nm23 gene, m23-H2. Cancer Res 51:445-449.
35. Steeg S, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LE, and Sobel ME (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200-204.
36. Steeg P, Bevilacqua G, Pozzatti R, Liotta LA, and Sobel ME (1988). Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 E1a inhibition of experimental metastasis. Cancer Res 48:6550-6554.
37. Travis WD, Linnoila RI, Tsokos MG, Hitchkock CL, Cutler GB, Nieman L, Chrousos G, Pass H, and Doppman J (1991). Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 15:529-553.
38. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M, and Lacombe ML (1900). Dictyostelium nucleoside diphosphate kinase highly homologous to nm23 and awd proteins involved in mammalian tumor metastasis and drosophila development. J Natl Cancer Inst 82:1199-1202.
39. WHO Classification (1981). Histological typing of lung tumors. International histological classification of tumors. Geneva: World Health Organisation.
40. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawara G, and Shiku H (1993). Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68:1020-1024.
41. Zeng ZS, Hsu S, Zhang ZF, Cohen AM, Enker WE, Turnbull AA, and Guillem JG (1994). High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer 70:1025-1030.